Aptevo Therapeutics Inc. (APVO) Free cash flow 2016–2022
Aptevo Therapeutics Inc. (APVO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$21.1MFY2022 · since FY2016: -$39.4M → -$21.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$21.1M | +6.0% |
| FY2021 | -$22.4M | +23.9% |
| FY2020 | -$29.4M | +30.9% |
| FY2019 | -$42.5M | +18.8% |
| FY2018 | -$52.4M | -21.9% |
| FY2017 | -$43.0M | -9.1% |
| FY2016 | -$39.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice